Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

TELESTA THERAPEUTICS INC > Similar drug gets breakthrough designation by FDA
View:
Post by wussy on Nov 27, 2014 8:16am

Similar drug gets breakthrough designation by FDA

MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer After phase 1 trials I believe. GLTA Wussy
Comment by cheetio on Nov 27, 2014 8:57am
coffin nail.......rip......Tumours shrunk for more than half of the patients after the received the new treatment for 12 weeks. Two of the patients were completely cured of the disease.
Comment by cheetio on Nov 27, 2014 9:00am
https://www.huffingtonpost.co.uk/2014/11/27/bladder-cancer-treatment-breakthrough-drug_n_6230360.html?utm_hp_ref=canada&ir=Canada
Comment by Tson99 on Nov 27, 2014 9:59am
This link is from May 31, 2014, I would think Bioniche management knows about this if it was really a nail in the coffin they would have changed their direction back in May. https://www.roche.com/media/media_releases/med-cor-2014-05-31.htm
Comment by NoNukNuk on Nov 27, 2014 12:36pm
now all they need is bnc's mcna for a full complement of bladder cancer drugs.  Here's hoping they will buy it and not be picking it up on bankruptcy.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities